MECIR Manual
Declarations of interest (R106)

Declarations of interest

  Standard Rationale and elaboration Resources
R106 Declarations of interest Mandatory  
 

Report any current or recent (within the 36 months prior to registration of the review) financial interests relevant to the topic of the review. This means payments from any commercial organization with an interest in the topic of the review. Include the dates of the involvement. 

Report any current or recent (within 36 months prior to registration of the review) non-financial relationships and activities that have a direct and obvious connection to the topic of the review. Include the dates of the involvement.

Report involvement in any study that may be eligible for inclusion in the review.   

Cochrane has two Conflict of Interest policies relating to Cochrane Library content. Which policy applies to a particular review depends on whether the review was registered before or after 14 October 2020. 

For reviews registered after 14 October 2020 the CoI Policy for Cochrane Library Content (2020) applies and for reviews registered before 14 October 2020 the Commercial Sponsorship Policy (2014) applies.

Declarations of interest should be stated according to the relevant CoI policy and must be consistent with interests declared on the Disclosure of Potential Conflicts of Interest form.
 

See Handbook  Section III.3.7 and EPPR Disclosure of potential conflict of interest by author policy

Cochrane Training resource: writing a protocol

 

 

Section info
Contact
support@cochrane.org
Describe change
26/02/2020
R106: See Handbook 2.6 -changed to- See Handbook (version 6) Section III.3.7 and EPPR Disclosure of potential conflict of interest by author policy

24/02/2021
R106: Report any present or recent (three years prior to declaration) affiliations or other involvement in any organization or entity with an interest in the review’s findings that might lead to a real or perceived conflict of interest. Include the dates of the involvement.  
-changed to-
Report any current or recent (within the 36 months prior to registration of the review) financial interests relevant to the topic of the review. This means payments from any commercial organization with an interest in the topic of the review. Include the dates of the involvement. Report any current or recent (within 36 months prior to registration of the review) non-financial relationships and activities that have a direct and obvious connection to the topic of the review. Include the dates of the involvement. Report involvement in any study that may be eligible for inclusion in the review.

R106: The full policy on conflicts of interest is available in the Cochrane Editorial and Publishing Policy Resource (EPPR). In brief, the nature and extent of the affiliation or involvement (whether financial or non-financial) should be described to promote transparency. Strategies to clarify how commercial and intellectual conflicts of interests (such as review authors who are trialists) were handled in the review process may be needed. Declarations of interest should be stated according to the relevant criteria from the International Committee of Medical Journal Editors (ICMJE), and must be consistent with interests declared on the Disclosure of Potential Conflicts of Interest form.
-changed to-
Cochrane has two Conflict of Interest policies relating to Cochrane Library content. Which policy applies to a particular review depends on whether the review was registered before or after 14 October 2020. For reviews registered after 14 October 2020 the CoI Policy for Cochrane Library Content (2020) applies and for reviews registered before 14 October 2020 the Commercial Sponsorship Policy (2014) applies. Declarations of interest should be stated according to the relevant CoI policy and must be consistent with interests declared on the Disclosure of Potential Conflicts of Interest form.

18/03/2021: removed (version 6) from all references to the Handbook as all references are to the most current version of the Handbook
Change date
18 March 2021
Share